Insider · CIK 0002048497

Hopman Mark

Reports to the SEC for 1 company · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0002048497

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-14	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−775 sh	$17.35	−$13.4K	55,334
2026-10-01	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−370 sh	$18.96	−$7,015.2	56,109
2026-09-16	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−30.8K sh	$20.13	−$620K	56,479
2026-09-14	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−775 sh	$15.52	−$12K	86,382
2026-09-09	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−36.9K sh	$18.46	−$681K	87,157
2026-09-09	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−36K sh	$18.46	−$665K	88,033
2026-09-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−5,327 sh	$19.11	−$102K	124,027
2026-06-24	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−1,258 sh	$15.01	−$18.9K	129,354
2026-06-04	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−275 sh	$12.31	−$3,385.25	130,612
2026-06-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−5,329 sh	$12.61	−$67.2K	130,887
2026-03-04	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−353 sh	$11.57	−$4,084.21	139,133
2026-03-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−834 sh	$12.36	−$10.3K	139,486
2026-02-27	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+91.5K sh	—	—	91,520
2026-02-27	BBNXBeta Bionics, Inc.A Award	Chief Commercial Officer	AAward	+109K sh	—	—	140,320
2026-02-27	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+58.7K sh	—	—	58,749
2025-12-04	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−2,061 sh	$30.66	−$63.2K	136,216
2025-12-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−856 sh	$29.34	−$25.1K	138,277
2025-09-05	BBNXBeta Bionics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+11.4K sh	$5.10	+$58.2K	42,626
2025-09-05	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−11.4K sh	$20.56	−$235K	31,215
2025-09-05	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−11.4K sh	—	—	21,725
2025-09-04	BBNXBeta Bionics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+656 sh	$5.10	+$3,345.6	33,940
2025-09-04	BBNXBeta Bionics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+4,093 sh	$5.10	+$20.9K	38,033
2025-09-04	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−6,818 sh	$19.97	−$136K	31,215
2025-09-04	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−656 sh	—	—	66,428
2025-09-04	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−4,093 sh	—	—	33,136
2025-09-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−848 sh	$18.86	−$16K	33,284
2025-08-19	BBNXBeta Bionics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+16.2K sh	$5.10	+$82.4K	50,290
2025-08-19	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−16.2K sh	$16.61	−$268K	34,132
2025-08-19	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−16.2K sh	—	—	67,084
2025-06-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−238 sh	$17.03	−$4,052.664	34,762
2025-06-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−551 sh	$18.15	−$10K	34,211
2025-06-02	BBNXBeta Bionics, Inc.S Sale	Chief Commercial Officer	SSale	−79 sh	$18.69	−$1,476.589	34,132
2025-02-27	BBNXBeta Bionics, Inc.A Award	Chief Commercial Officer	AAward	+35K sh	—	—	35,000
2025-02-27	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+52K sh	—	—	52,000
2025-01-31	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+83.2K sh	—	—	83,242
2025-01-31	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+37.2K sh	—	—	37,229
2025-01-31	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+17.8K sh	—	—	17,765
2025-01-31	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+39.4K sh	—	—	39,424
2025-01-31	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+47.8K sh	—	—	47,775
2025-01-29	BBNXBeta Bionics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+47.8K sh	—	—	47,775

Recent filings

Accepted (ET)
Oct 164
Hopman Mark0002048497-26-000021
SEC(opens sec.gov)
Oct 54
Hopman Mark0002048497-26-000018
SEC(opens sec.gov)
Sep 184/A
Hopman Mark0002048497-26-000016
SEC(opens sec.gov)
Sep 174
Hopman Mark0002048497-26-000015
SEC(opens sec.gov)
Sep 154
Hopman Mark0002048497-26-000014
SEC(opens sec.gov)
Sep 104
Hopman Mark0002048497-26-000013
SEC(opens sec.gov)
Sep 34
Hopman Mark0002048497-26-000012
SEC(opens sec.gov)
Jun 254
Hopman Mark0002048497-26-000009
SEC(opens sec.gov)
Jun 54
Hopman Mark0002048497-26-000008
SEC(opens sec.gov)
Jun 34
Hopman Mark0002048497-26-000007
SEC(opens sec.gov)
Mar 164
Hopman Mark0002048497-26-000004
SEC(opens sec.gov)
Mar 134/A
Hopman Mark0002048497-26-000003
SEC(opens sec.gov)
Mar 54
Hopman Mark0002048497-26-000002
SEC(opens sec.gov)
Mar 34
Hopman Mark0002048497-26-000001
SEC(opens sec.gov)
Sep 84
Hopman Mark0001415889-25-023899
SEC(opens sec.gov)

Companies

Beta Bionics, Inc.Chief Commercial OfficerBBNX

Address

C/O BETA BIONICS, INC. 11 HUGHES

IRVINE, CA, 92618